Desq Long
Sign in

Company

Beta Bionics, Inc.

BBNX · CIK 0001674632

SEC FORM 4
$147,890.00

Beta Bionics, Inc. (BBNX)

Sale of 6,430 shares at $23 per share.

Reporting Person Jones Christy · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0002048467-26-000007 · filed 2026-09-23 · View filing →

SEC FORM 4
$664,550.02

Beta Bionics, Inc. (BBNX)

Sale of 35,994 shares at $18.4628 per share.

Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 18, 2026FILED +9 DAYS

Source: SEC Form 4 · 0002048497-26-000016 · filed 2026-09-18 · View filing →

SEC FORM 4
$619,639.75

Beta Bionics, Inc. (BBNX)

Sale of 30,779 shares at $20.1319 per share.

Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0002048497-26-000015 · filed 2026-09-17 · View filing →

SEC FORM 4
$58,300.00

Beta Bionics, Inc. (BBNX)

Sale of 2,650 shares at $22 per share.

Reporting Person Mensinger Mike · Officer Title Chief Product Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0002048500-26-000013 · filed 2026-09-17 · View filing →

SEC FORM 4
$12,028.00

Beta Bionics, Inc. (BBNX)

Sale of 775 shares at $15.52 per share.

Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0002048497-26-000014 · filed 2026-09-15 · View filing →

SEC FORM 4
$113,258.87

Beta Bionics, Inc. (BBNX)

Sale of 5,641 shares at $20.0778 per share.

Reporting Person Saint Sean · Officer Title President & CEO · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002048593-26-000010 · filed 2026-09-04 · View filing →

SEC FORM 4
$101,815.48

Beta Bionics, Inc. (BBNX)

Sale of 5,327 shares at $19.1131 per share.

Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002048497-26-000012 · filed 2026-09-03 · View filing →

SEC FORM 4
$83,619.81

Beta Bionics, Inc. (BBNX)

Sale of 4,375 shares at $19.1131 per share.

Reporting Person Mensinger Mike · Officer Title Chief Product Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002048500-26-000012 · filed 2026-09-03 · View filing →

SEC FORM 4
$127,579.94

Beta Bionics, Inc. (BBNX)

Sale of 6,675 shares at $19.1131 per share.

Reporting Person Feider Stephen · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002048588-26-000013 · filed 2026-09-03 · View filing →

SEC FORM 4
$322,380.66

Beta Bionics, Inc. (BBNX)

Sale of 16,867 shares at $19.1131 per share.

Reporting Person Saint Sean · Officer Title President & CEO · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002048593-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$80,676.40

Beta Bionics, Inc. (BBNX)

Sale of 4,221 shares at $19.1131 per share.

Reporting Person Russell Steven Jon · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0002051384-26-000009 · filed 2026-09-03 · View filing →